4//SEC Filing
Bellemin Jean-Marc 4
Accession 0001104659-25-021062
CIK 0001425205other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:33 PM ET
Size
9.9 KB
Accession
0001104659-25-021062
Insider Transaction Report
Form 4
Bellemin Jean-Marc
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-03+58,590→ 87,938 total - Exercise/Conversion
Restricted Stock Units
2025-03-03−58,590→ 70,317 total→ Common Stock (58,590 underlying) - Tax Payment
Common Stock
2025-03-03$4.04/sh−31,734$128,205→ 56,204 total
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan.
- [F3]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F4]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F5]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F6]The remaining RSUs will vest in equal quarterly installments.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001754253
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 8:33 PM ET
- Size
- 9.9 KB